SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-14-008221
Filing Date
2014-05-07
Accepted
2014-05-07 16:58:22
Documents
26
Period of Report
2014-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K furx20140506_8k.htm 8-K 20768
2 EXHIBIT 99.1 ex99-1.htm EX-99 122408
3 EXHIBIT 99.2 ex99-2.htm EX-99 14078
4 slide22.jpg GRAPHIC 62231
5 slide21.jpg GRAPHIC 130145
6 slide20.jpg GRAPHIC 83378
7 slide19.jpg GRAPHIC 127214
8 slide18.jpg GRAPHIC 128359
9 slide17.jpg GRAPHIC 103022
10 slide16.jpg GRAPHIC 114013
11 slide15.jpg GRAPHIC 70298
12 slide14.jpg GRAPHIC 92233
13 slide13.jpg GRAPHIC 63439
14 slide12.jpg GRAPHIC 28077
15 slide11.jpg GRAPHIC 65063
16 slide10.jpg GRAPHIC 68131
17 slide9.jpg GRAPHIC 54153
18 slide8.jpg GRAPHIC 52678
19 slide7.jpg GRAPHIC 94727
20 slide6.jpg GRAPHIC 100886
21 slide5.jpg GRAPHIC 124420
22 slide4.jpg GRAPHIC 66332
23 slide3.jpg GRAPHIC 70548
24 slide2.jpg GRAPHIC 103537
25 slide1.jpg GRAPHIC 77202
26 ex99-1img001.jpg GRAPHIC 5135
  Complete submission text file 0001437749-14-008221.txt   2758640
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 14821801
SIC: 2834 Pharmaceutical Preparations